Insider · CIK 0001261770
Dale H Conaway
Files at BIXT (BIOXYTRAN, INC). First filing -, latest -.
In brief
Dale H Conaway files SEC Form 4 as director at BIXT (BIOXYTRAN, INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dale H Conaway has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | BIXT BIOXYTRAN, INC | AGrant or award preferred | +10,417 | $0.49 | $5,052 | 340,589 | Nov 18, 2025 |
| Nov 14, 2025 | BIXT BIOXYTRAN, INC | AGrant or award preferred | +38,588 | $0.35 | $14k | 379,177 | Nov 18, 2025 |
| Jan 6, 2025 | BIXT BIOXYTRAN, INC | AGrant or award Preferred | +97,535 | $0.32 | $31k | 330,172 | Jan 14, 2025 |
| Oct 25, 2024 | BIXT BIOXYTRAN, INC | AGrant or award preferred | +20,619 | $0.46 | $9,485 | 232,637 | Oct 28, 2024 |
| Mar 27, 2024 | BIXT BIOXYTRAN, INC | AGrant or award common | +266,955 | $0.11 | $30k | 855,476 | Mar 27, 2024 |
| Oct 31, 2023 | BIXT BIOXYTRAN, INC | AGrant or award common | +77,721 | $0.19 | $15k | 588,521 | Nov 2, 2023 |
Questions about Dale H Conaway
Answered from the filings on this page, as of the latest one.
Is Dale H Conaway buying or selling?
Dale H Conaway has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dale H Conaway's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dale H Conaway has 0.
Where does Dale H Conaway file Form 4?
Dale H Conaway has filed Form 4 at BIXT (BIOXYTRAN, INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.